NNC6022-0004
/ Novo Nordisk
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 20, 2026
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
(clinicaltrials.gov)
- P1 | N=128 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity • CRP
July 10, 2026
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
(clinicaltrials.gov)
- P1 | N=128 | Not yet recruiting | Sponsor: Novo Nordisk A/S
New P1 trial • Genetic Disorders • Obesity • CRP
1 to 2
Of
2
Go to page
1